# ImmVira Pharma

Source: https://onco.cc/companies/immvira-pharma/  
OnCo record `immvira-pharma` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

ImmVira Pharma is a Chinese developer in Shenzhen that sponsors 3 registered cancer trials of Herpes Virus C5252 and T3011.

## Summary

ImmVira Pharma appears on ClinicalTrials.gov as the industry sponsor of 3 interventional cancer trials (phase 1/2, 2), testing Herpes Virus C5252, T3011 in glioma, malignant, nonmuscle-invasive bladder cancer, solid tumor, melanoma. OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: ImmVira Pharma Co. Ltd
- Tags: ctgov-sponsor; china; registry-only
- HQ: Shenzhen, China
- Type: biotech

## Sources

- ClinicalTrials.gov: trials sponsored by ImmVira Pharma: https://clinicaltrials.gov/search?spons=ImmVira%20Pharma

## Connected records

- trials: [A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Adva](https://onco.cc/trials/nct04370587/), [A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor](https://onco.cc/trials/nct07243340/), [A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC](https://onco.cc/trials/nct06971614/)

---
JSON: https://onco.cc/api/v1/entities/immvira-pharma.json